November 23, 2010
Blurb
NEW YORK (WABC) Dr. Jay Adlersberg -- The National Institute on Drug Abuse reports that in 2008, almost 2 million Americans depend on or are addicted to narcotic pain killers, but there's a new development in treatment...
"It's a breakthrough because it's the first preparation of a long acting blocker that makes it feasible to use in patients," Dr. Adam Bisaga of Columbia Psychiatry said.
A blocker is any drug that prevents the action of another.
Studies show that Vivitrol works by blocking 100% of the narcotic receptors in the brain. Narcotics can't attach to brain cells and have no effect on the patient.
Read more and watch the video at http://abclocal.go.com/wabc/story?section=news/health&id=7803787
"It's a breakthrough because it's the first preparation of a long acting blocker that makes it feasible to use in patients," Dr. Adam Bisaga of Columbia Psychiatry said.
A blocker is any drug that prevents the action of another.
Studies show that Vivitrol works by blocking 100% of the narcotic receptors in the brain. Narcotics can't attach to brain cells and have no effect on the patient.
Read more and watch the video at http://abclocal.go.com/wabc/story?section=news/health&id=7803787